Nomura Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.12M Buy
71,113
+341
+0.5% +$29.9K 0.01% 582
2026
Q1
$6.4M Buy
70,772
+5,406
+8% +$496K 0.02% 535
2025
Q4
$5.88M Buy
65,366
+352
+0.5% +$33.4K 0.01% 569
2025
Q3
$6.4M Sell
65,014
-148
-0.2% -$14.7K 0.02% 542
2025
Q2
$5.94M Buy
65,162
+472
+0.7% +$45.6K 0.02% 559
2025
Q1
$7.32M Buy
64,690
+4,256
+7% +$455K 0.02% 497
2024
Q4
$6.38M Buy
60,434
+468
+0.8% +$50.2K 0.02% 520
2024
Q3
$6.47M Buy
59,966
+3,628
+6% +$396K 0.02% 512
2024
Q2
$6.11M Sell
56,338
-1,198
-2% -$141K 0.02% 497
2024
Q1
$7.59M Buy
57,536
+301
+0.5% +$37.6K 0.03% 447
2023
Q4
$6.97M Buy
57,235
+1,935
+3% +$216K 0.03% 452
2023
Q3
$6.21M Sell
55,300
-1,671
-3% -$212K 0.03% 446
2023
Q2
$8.29M Buy
56,971
+2
+0% +$272 0.04% 392
2023
Q1
$7.36M Buy
56,969
+2,135
+4% +$268K 0.04% 402
2022
Q4
$6.99M Buy
54,834
+2,475
+5% +$287K 0.04% 394
2022
Q3
$5.47M Buy
52,359
+2,733
+6% +$300K 0.03% 422
2022
Q2
$5.21M Buy
49,626
+2,176
+5% +$258K 0.03% 438
2022
Q1
$6.07M Buy
47,450
+236
+0.5% +$28.4K 0.03% 443
2021
Q4
$5.82M Buy
47,214
+2,452
+5% +$321K 0.03% 458
2021
Q3
$6.36M Buy
44,762
+2,011
+5% +$296K 0.04% 402
2021
Q2
$6.67M Buy
42,751
+257
+0.6% +$41.6K 0.04% 407
2021
Q1
$6.6M Buy
42,494
+1,446
+4% +$224K 0.04% 388
2020
Q4
$6.14M Buy
41,048
+1,039
+3% +$147K 0.04% 373
2020
Q3
$5.29M Sell
40,009
-1,012
-2% -$132K 0.04% 361
2020
Q2
$4.75M Buy
41,021
+1,749
+4% +$202K 0.04% 367
2020
Q1
$3.85M Buy
39,272
+1,051
+3% +$138K 0.04% 368
2019
Q4
$5.55M Buy
38,221
+398
+1% +$54.9K 0.05% 327
2019
Q3
$5.04M Buy
37,823
+1,736
+5% +$224K 0.05% 333
2019
Q2
$4.13M Sell
36,087
-363
-1% -$42.5K 0.04% 360
2019
Q1
$4.52M Buy
36,450
+475
+1% +$54K 0.04% 341
2018
Q4
$3.62M Buy
35,975
+2,609
+8% +$293K 0.04% 359
2018
Q3
$4.26M Sell
33,366
-922
-3% -$110K 0.04% 344
2018
Q2
$3.71M Buy
34,288
+1,622
+5% +$177K 0.04% 367
2018
Q1
$3.46M Buy
32,666
+1,292
+4% +$150K 0.04% 367
2017
Q4
$3.67M Buy
31,374
+1,972
+7% +$223K 0.04% 347
2017
Q3
$3.34M Buy
29,402
+1,983
+7% +$229K 0.04% 347
2017
Q2
$3.42M Sell
27,419
-164
-0.6% -$19.4K 0.05% 330
2017
Q1
$3.27M Buy
27,583
+2,305
+9% +$261K 0.05% 342
2016
Q4
$2.53M Sell
25,278
-3,183
-11% -$341K 0.05% 363
2016
Q3
$3.59M Sell
28,461
-6,056
-18% -$748K 0.06% 297
2016
Q2
$4.03M Buy
34,517
+1,030
+3% +$117K 0.08% 265
2016
Q1
$3.47M Buy
33,487
+11,381
+51% +$1.1M 0.07% 278
2015
Q4
$2.2M Buy
22,106
+845
+4% +$82.7K 0.04% 367
2015
Q3
$1.94M Buy
21,261
+2,240
+12% +$225K 0.04% 387
2015
Q2
$2.02M Sell
19,021
-309
-2% -$34.2K 0.04% 377
2015
Q1
$2.21M Sell
19,330
-443
-2% -$50.5K 0.04% 365
2014
Q4
$2.2M Sell
19,773
-433
-2% -$45.6K 0.04% 372
2014
Q3
$1.97M Hold
20,206
0.03% 373
2014
Q2
$2.04M Sell
20,206
-66,633
-77% -$6.5M 0.04% 370
2014
Q1
$7.97M Buy
86,839
+9,307
+12% +$858K 0.15% 158
2013
Q4
$7.01M Buy
77,532
+53,969
+229% +$4.67M 0.13% 179
2013
Q3
$1.88M Sell
23,563
-8,692
-27% -$684K 0.04% 393
2013
Q2
$2.35M Buy
+32,255
New +$2.41M 0.05% 377

Other funds holding ZBH

Nomura Asset Management's ZBH Position: Q2 2026 in Review

Nomura Asset Management increased its Zimmer Biomet (ZBH) stake by 0.48% in Q2 2026, buying an estimated $29.9K and bringing the position to 71,113 shares worth $6.12M. The position accounts for 0.01% of the portfolio, ranked #582.

Nomura Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.29M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Nomura Asset Management held 71,113 shares of Zimmer Biomet worth $6.12M as of Q2 2026.
  • Nomura Asset Management bought 341 Zimmer Biomet shares in Q2 2026, an estimated $29.9K.
  • Zimmer Biomet made up 0.01% of Nomura Asset Management's portfolio in Q2 2026, its #582 holding.
  • Nomura Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Nomura Asset Management's Zimmer Biomet position peaked at $8.29M in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.